Observations placeholder
Solu-medrol
Identifier
020041
Type of Spiritual Experience
Background
A description of the experience
Methylprednisolone is a synthetic glucocorticoid or corticosteroid drug. It is marketed in the USA and Canada under the brand names Medrol and Solu-Medrol. It is also available as a generic drug.
It is a variant of prednisolone, methylated at carbon 6 of the B ring.
Long-term use of methylprednisolone, as with all corticosteroids, can be associated with hyperglycemia, decreased resistance to infection, swelling of face, weight gain, congestive cardiac insufficiency, fluid and sodium retention, edema, hypertension, increased eye pressure, glaucoma, osteoporosis, and psychosis, especially when used at high doses. The most serious side effect occurs after the adrenal glands cease natural production of cortisol, which methylprednisolone will replace. Abrupt cessation of the drug after this occurs can result in a condition known as Addisonian crisis, which can be fatal. To prevent this, the drug is usually prescribed with a tapering dose, including a predosed "dose pack" detailing a specific number of tablets to take at designated times over a several-day period. Pharmacists sometimes advise that this drug may cause sleeplessness and "down" moods.
Individuals on methylprednisolone therapy should assiduously avoid exposure to measles and chicken pox, as contracting these viral infections while on high-dose corticosteroids can result in a potentially fatal viral course. Any accidental exposure to these viral infections by individuals uncertain of their immunity to chicken pox or measles should be reported immediately as prophylactic immunoglobulin therapy may be administered. Additionally, the administration of live, attenuated vaccines is contraindicated for individuals taking immunosuppressive doses of methylprednisolone. The exception to this rule is patients receiving complete corticosteroid replacement therapy, e.g., for Addison's disease, who may follow standard immunization protocols.
On Feb, 1, 2016: 14,755 people reported to have side effects when taking Solu-medrol. Among them, 112 people (0.76%) have Hallucination.
Time on Solu-medrol when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Solu-medrol :
| Female | Male | |
| Hallucination | 55.65% | 44.35% |
Age of people who have Hallucination when taking Solu-medrol :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 3.60% | 7.21% | 6.31% | 0.90% | 3.60% | 18.92% | 18.02% | 41.44% |
On Jan, 19, 2016: 14,755 people reported to have side effects when taking Solu-medrol. Among them, 359 people (2.43%) have Death.
Time on Solu-medrol when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 91.67% | 6.67% | 0.83% | 0.00% | 0.00% | 0.00% | 0.83% |
Gender of people who have Death when taking Solu-medrol :
| Female | Male | |
| Death | 51.61% | 48.39% |
Age of people who have Death when taking Solu-medrol :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 1.53% | 3.98% | 2.45% | 0.92% | 7.65% | 5.50% | 21.41% | 56.57% |